ACRS Quote, Trading Chart, Aclaris Therapeutics Inc.
home / stock / acrs / acrs quote
$20.67 Last:
-1.67% Change Percent:
$20.96 Open:
$20.67 Previous Close:
$21.5768 High:
$20.305 Low:
579,581 Volume:
02/24/2021 04:55:18 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-02-24 | 20.96 | 20.67 | 21.5768 | 20.305 | 579,581 |
| 2021-02-23 | 21.55 | 21.02 | 21.83 | 20 | 981,964 |
| 2021-02-22 | 20.51 | 23.03 | 25 | 19.51 | 3,126,075 |
| 2021-02-19 | 22.9 | 21.2 | 23.6 | 21.18 | 766,207 |
| 2021-02-18 | 23.44 | 22.6 | 23.84 | 22.06 | 580,321 |
| 2021-02-17 | 24.19 | 23.86 | 24.305 | 22.87 | 490,814 |
| 2021-02-16 | 24.26 | 23.93 | 24.43 | 23.51 | 590,524 |
| 2021-02-15 | 22.82 | 24.21 | 25.48 | 22.54 | 639,920 |
| 2021-02-12 | 22.82 | 24.21 | 25.48 | 22.54 | 639,897 |
| 2021-02-11 | 23.3 | 23.27 | 23.97 | 22.55 | 592,662 |
| 2021-02-10 | 21.4 | 22.93 | 22.97 | 21.31 | 793,935 |
| 2021-02-09 | 20.94 | 21.5 | 23.85 | 20.94 | 1,093,380 |
| 2021-02-08 | 20.01 | 20.95 | 21.73 | 20.01 | 563,716 |
| 2021-02-05 | 21.5 | 20.77 | 21.62 | 20.26 | 804,816 |
| 2021-02-04 | 21.5 | 21.56 | 23.3 | 21.26 | 1,438,776 |
| 2021-02-03 | 20.73 | 21.5 | 21.64 | 20.54 | 728,704 |
| 2021-02-02 | 21.66 | 20.73 | 22.2 | 20.6404 | 945,052 |
| 2021-02-01 | 21.06 | 21.35 | 21.75 | 20.2501 | 1,065,184 |
| 2021-01-29 | 20 | 20.75 | 21.429 | 19.4901 | 799,650 |
| 2021-01-28 | 18.96 | 19.52 | 21.975 | 17.9829 | 2,443,315 |
Aclaris Therapeutics Inc. Company Name:
ACRS Stock Symbol:
NASDAQ Market:
Aclaris Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
WAYNE, Pa., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will present ...
-
WAYNE, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that management will participate in a virtual fireside chat at th...
-
Shares of Aclaris Therapeutics (NASDAQ: ACRS) surged on Tuesday, following the release of promising data regarding its experimental treatment for rheumatoid arthritis. As of 12:20 a.m. EST today, the pharmaceutical company's stock price was up 212%. Aclaris Therapeutics ...